FDA Warns About Bacterial Contamination of Skin Products Made by Clarcon

Article

The Food and Drug Administration (FDA) announces that Clarcon Biological Chemistry Laboratory Inc. of Roy, Utah, is voluntarily recalling some skin sanitizers and skin protectants marketed under several different brand names because of high levels of disease-causing bacteria found in the product during a recent inspection. The FDA is warning consumers to not use any Clarcon products.

Consumers should not use any Clarcon products and should throw these products away in household refuse. Analyses of several samples of over-the-counter topical antimicrobial skin sanitizer and skin protectant products revealed high levels of various bacteria, including some associated with unsanitary conditions. Some of these bacteria can cause opportunistic infections of the skin and underlying tissues.  Such infections may need medical or surgical attention, and may result in permanent damage. Examples of products that should be discarded include:

-- Citrushield Lotion

-- Dermasentials DermaBarrier

-- Dermassentials by Clarcon Antimicrobial Hand Sanitizer

-- Iron Fist Barrier Hand Treatment

-- Skin Shield Restaurant

-- Skin Shield Industrial

-- Skin Shield Beauty Salon Lotion

-- Total Skin Care Beauty

-- Total Skin Care Work

Findings from the FDA’s recent inspection of the Clarcon facility are particularly concerning because the products are promoted as antimicrobial agents that claim to treat open wounds, damaged skin, and protect against various infectious diseases.  The inspection uncovered serious deviations from FDA’s current Good Manufacturing Practice requirements.

 

 

 

Recent Videos
Meet Jenny Hayes, MSN, RN, CIC, CAIP, CASSPT.
Veterinary Infection Prevention
Andreea Capilna, MD, PhD
Meet the Infection Control Today Editorial Advisory Board Members: Priya Pandya-Orozco, DNP, MSN, RN, PHN, CIC.
Meet Matthew Pullen, MD.
Henry Spratt, Infection Control Today's Editorial Advisory Board member
Antimicrobial Resistance (Adobe Stock unknown)
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Lucy S. Witt, MD, investigates hospital bed's role in C difficile transmission, emphasizing room interactions and infection prevention
Related Content